TITLE:
Drug-Induced Hemolytic Anemia: A Fatal Complication Further Under-Recognized in Sickle Cell Disease
AUTHORS:
Monica Khurana, Shekhar S. Raj
KEYWORDS:
Sickle Cell, Hemolytic Anemia, Blood Bank, Pathology
JOURNAL NAME:
Open Journal of Blood Diseases,
Vol.7 No.3,
September
25,
2017
ABSTRACT: Drug-induced immune hemolytic anemia (DIIHA) is commonly attributed to cephalosporins. Ceftriaxone is the most frequently administered cephalosporin in patients with sickle cell disease. We present a pediatric patient with severe DIIHA (hemoglobin